First wave of implants efficiently accomplished with up to date supply system performing very nicely Firm on schedule to be…
First scientific presentation of beforehand introduced information from Cohort 1 of the continuing Section 1b medical trial evaluating low-dose LTI-03…
Our selection of the week's biggest research news and features sent directly to your inbox. Enter your email address, confirm you're happy to receive our emails.
Please contact salesdepartment
for further information at:
Sales@88.broker
Sign in to your account